Inhibition of chymase reduces vascular proliferation in dog grafted veins

FEBS Letters

Volumn 467, Issue 2-3, 2000, Pages 141-144

  Takai, Shinji ^a   Yuda, Atsushi ^a   Jin, Denan ^a   Nishimoto, Masayoshi ^a   Sakagichi, Masato ^a   Sasaki, Shinjiro ^a   Miyazaki, Mizuo ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Angiotensin II; Angiotensin converting enzyme; Chymase; Inhibitor

Indexed keywords

ANGIOTENSIN; CHYMASE; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO; SUCCINYLVALYLPROLYLPHENYLALANINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; ENZYME INHIBITION; NONHUMAN; PRIORITY JOURNAL; VASCULAR TISSUE; VASCULARIZATION; VEIN GRAFT;

ANIMALS; CHYMASES; DOGS; OLIGOPEPTIDES; SERINE ENDOPEPTIDASES; SERINE PROTEINASE INHIBITORS; TIME FACTORS; TUNICA INTIMA; VASOCONSTRICTION; VEINS;

CANIS FAMILIARIS;

EID: 0033983720     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(00)01125-X     Document Type: Article

References (23)

1. Walker L.N., Bowen Pope D.F., Ross R., Reidy M.A. Proc. Natl. Acad. Sci. USA. 83:1986;7311-7315.
2. Naftilan A.J., Pratt R.E., Dzau V.J. J. Clin. Invest. 83:1989;1419-1424.
3. Schelling H., Fischer H., Ganten D. J. Hypertens. 9:1991;3-15.
4. Takai S., Shiota N., Kobayashi S., Matsumura E., Miyazaki M. FEBS Lett. 412:1997;86-90.
5. Takai S., Shiota N., Yamamoto D., Okunishi H., Miyazaki M. Life Sci. 58:1996;591-597.
6. Okunishi H., Oka Y., Shiota N., Kawamoto T., Song K., Miyazaki M. Jpn. J. Pharmacol. 62:1993;207-210.
7. Takai S., Shiota N., Sakaguchi M., Muraguchi H., Matsumura E., Miyazaki M. Clin. Chim. Acta. 265:1997;13-20.
8. Takai S., Jin D., Sakagichi M., Miyazaki M. Circulation. 100:1999;654-658.
9. Wintroub B.U., Schechter N.B., Lazarus G.S., Kaempfer C.E., Schwartz L.B. J. Invest. Dermatol. 83:1984;336-339.
10. Le Trong H., Neurath H., Woodbury R.G. Proc. Natl. Acad. Sci. USA. 84:1987;364-367.
11. Powell J.S., Clozel J.P., Muler R.K.M., Kuhn H., Hefti F., Hosang M., Baumgartner H.R. Science. 245:1991;186-188.
12. MERCATOR Study Group (1992) Circulation 86, 100-110.
13. Roux S.P., Clozel J.P., Kuhn H. Hypertension. 18:(Suppl. 4):1991;II43-II46.
14. Hanson S.R., Powell J.S., Dodson T., Lumsden A., Kelly A.B., Anderson J.S., Clowes A.W., Harker L.A. Hypertension. 18:(Suppl. 4):1991;II70-II76.
15. Oleksyszyn J., Powers J.C. Biochemistry. 30:1991;485-493.
16. Takai S., Shiota N., Jin D., Miyazaki M. J. Cardiovasc. Pharmacol. 32:1998;826-833.
17. Miyazaki M., Okunishi H., Nishimura K., Toda N. Clin. Sci. 66:1984;39-45.
18. Jin D., Takai S., Shiota N., Miyazaki M. J. Hypertens. 16:1998;657-664.
19. Miyazaki M., Wada T., Shiota N., Takai S. J. Hum. Hypertens. 12:(Suppl. 1):1999;S21-S25.
20. Craig S.S., Schwartz L.B. Lab. Invest. 63:1990;581-585.
21. Pejler G., Berg L. Eur. J. Biochem. 233:1995;192-199.
22. McEuen A.R., Sharma B., Walls A.F. Biochim. Biophys. Acta. 1267:1995;115-121.
23. Zhang S., Anderson D.F., Bradding P., Coward W.R., Baddeley S.M., MacLeod J.D., McGill J.I., Church M.K., Holgate S.T., Roche W.R. J. Pathol. 186:1998;59-66.